- Home
- TRNR vs PRFX Comparison
TRNR vs PRFX Comparison
Compare TRNR & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRNR | PRFX |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 2.7M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TRNR | PRFX |
|---|---|---|
| Price | $0.62 | $0.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.6M | ★ 3.7M |
| Earning Date | 11-14-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,774,000.00 | N/A |
| Revenue This Year | $245.67 | N/A |
| Revenue Next Year | $308.85 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 207.36 | N/A |
| 52 Week Low | $0.61 | $0.61 |
| 52 Week High | $39.60 | $6.65 |
Technical Indicators
Market Signals| Indicator | TRNR | PRFX |
|---|---|---|
| Relative Strength Index (RSI) | 24.69 | 45.33 |
| Support Level | $0.64 | $0.85 |
| Resistance Level | $1.62 | $1.59 |
| Average True Range (ATR) | 0.15 | 0.13 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.66 | 13.62 |
Price Performance
Historical ComparisonAbout TRNR Interactive Strength Inc.
Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.